COMMUNIQUÉS West-GlobeNewswire

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 mars 2024

23/04/2024 - 17:09

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 mars 2024 En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, les [...]

SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024

23/04/2024 - 16:29

BOSTON and ROLLE, Switzerland, April 23, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the [...]

Survey: Physicians Turning to Locum Tenens to Improve Work Conditions, Relieve Burnout

23/04/2024 - 16:00

Many Would Return to Permanent Positions If Conditions Right DALLAS, April 23, 2024 (GLOBE NEWSWIRE) -- Physicians and advanced practice professionals are opting for the flexibility of temporary, “locum tenens” work in [...]

HealthSource of Ohio names Jody Prather, MD, as its President and CEO

23/04/2024 - 16:00

CINCINNATI, April 23, 2024 (GLOBE NEWSWIRE) -- HealthSource of Ohio announced today the appointment of Jody Prather, MD as its next President and Chief Executive Officer following an extensive, nationwide search process [...]

Epic Bio Presents New Data Highlighting Potential of EPI-321 for FSHD and Epigenetic Editing Platform Leadership at ASGCT Annual Meeting

23/04/2024 - 15:00

- Across robust slate of presentations, company highlights compelling new data and strong differentiation - SOUTH SAN FRANCISCO, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Epic Bio , a leading epigenetic editing company [...]

Visory Health Secures Women’s Business Enterprise National Council Certification for Third Consecutive Year

23/04/2024 - 15:00

The Florida-based, woman-owned business granting accessible, affordable prescriptions to underserved populations joins 18,000 other prestigious female-led companies after rigorous vetting ESTERO, Fla., April 23, 2024 ( [...]

Viemed Healthcare Announces Date and Time for Conference Call

23/04/2024 - 15:00

LAFAYETTE, La., April 23, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “ Company ” or “ Viemed ”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, [...]

NeurAxis Announces New Medical Policy Coverage in North Dakota

23/04/2024 - 15:00

CARMEL, Ind., April 23, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and [...]

Mobile-health Network and Online Pharmacy, Lifepack, Sign Partnership Facilitating Cooperation in Singapore and Indonesia

23/04/2024 - 15:00

SINGAPORE, April 23, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) (“MaNaDr” or the “Company”), a pioneering Asia-Pacific (“APAC”) telehealth provider, has announced a strategic partnership [...]

ICU Medical Announces Time of First Quarter 2024 Earnings Conference Call

23/04/2024 - 14:30

SAN CLEMENTE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter [...]

Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon

23/04/2024 - 14:30

IRVINE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for [...]

STRATA Skin Sciences to Present at the Planet MicroCap Showcase: Vegas 2024

23/04/2024 - 14:30

HORSHAM, Pa., April 23, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative [...]

Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer Therapy

23/04/2024 - 14:30

Provides Further Evidence of Multiple Opportunities for Development of the FABP Inhibitor Platform in Cancer & Other Serious Conditions SOLANA BEACH, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, [...]

GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset

23/04/2024 - 14:30

The Company will also participate in a World Orphan Drug Congress panel presentation highlighting the role of genomic sequencing in advancing precision medicine STAMFORD, Conn., April 23, 2024 (GLOBE NEWSWIRE) -- GeneDx [...]

PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101

23/04/2024 - 14:30

TARRYTOWN, New York, April 23, 2024 (GLOBE NEWSWIRE) -- via IBN – PaxMedica Inc. (Nasdaq: PXMD) (the “Company”), a leading biopharmaceutical company dedicated to advancing treatments for neurological disorders, expects [...]

Palisade Bio Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine Approach

23/04/2024 - 14:30

– Collaboration grants Palisade Bio access to cutting-edge expertise and tools in bioinformatics – Partnership marks a significant value-driving milestone in Palisade Bio's mission to redefine UC treatment through [...]

Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA Editing

23/04/2024 - 14:30

GSK has selected the first two programs to advance following achievement of target validation, marking transition to next phase of research collaboration; programs utilize Wave’s next generation GalNAc-siRNA format with [...]

Optimi Health and Kwantlen Polytechnic University Applied Genomics Centre Partner to Advance Mushroom Science and Research

23/04/2024 - 14:18

VANCOUVER, British Columbia, April 23, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed psychedelics pharmaceutical manufacturer, is thrilled to [...]

USDA Grants Amfora Exemption for Its Patented, Gene-Edited, Ultra-High Protein Soy, Accelerating Path to Market

23/04/2024 - 14:15

SAN FRANCISCO, April 23, 2024 (GLOBE NEWSWIRE) -- The U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) has granted Amfora, Inc. an exemption for its gene-edited, ultra-high protein [...]